machine learning Archives -

Digital/ Healthcare/ Insights/ Insights/ Insights/ Insights/ Market Access/ Oncology/ Patients/ Pharma Market Access/ Podcast/ R&D/ Sales and Marketing/ Transversal Categories/ Video/ Views and analysis

A few of 2022’s biggest pharma trends – the pharmaphorum podcast

Jonah Comstock 2023 trends, AI, clinical trials, covid19, digital health, machine learning, Oncology, patient centricity, pharma trends, pharmaphorum, precision medicine 0 Comment

As we close out the year, pharmaphorum’s editorial team sat down together for a roundtable discussion of some

A few of 2022’s biggest pharma trends – the pharmaphorum podcast

https://pharmaphorum.com/podcast/a-few-of-2022s-biggest-pharma-trends/

Events/ Insights/ Reuters Pharma 2022/ Sales and Marketing/ Views and analysis

A Reuters Pharma conversation with EY: smart reviewing and payment outcomes

Nicole Raleigh AI, data, EY Consulting, health outcomes, machine learning, patient centricity, payment outcomes, pharma, Reuters Pharma, Smart Reviewer 0 Comment

Harking back to the Reuters Pharma 2022 event, held at the Nice Acropolis convention centre on France’s South

A Reuters Pharma conversation with EY: smart reviewing and payment outcomes

https://pharmaphorum.com/views-and-analysis/a-reuters-pharma-conversation-with-ey-smart-reviewing-and-payment-outcomes/

Digital/ R&D/ Views & Analysis/ Views & Analysis/ Views and analysis

Artificial Intelligence for better antibody drugs: ready for prime time?

mike.hammerton@pharmaphorum.com AI, biopharma, data, deep leaning, discovery, hit identification, hit optimisation, mAbs, machine learning, monoclonal antibodies 0 Comment

The potential of monoclonal antibodies (mAbs) as therapies is indisputable. The current mAbs market is expected to be

Artificial Intelligence for better antibody drugs: ready for prime time?

https://pharmaphorum.com/views-and-analysis/artificial-intelligence-for-better-antibody-drugs-ready-for-prime-time/

Digital/ News/ News/ News/ R&D

GSK turns to AI specialist Tempus for R&D productivity boost

Phil Taylor artificial intelligence, clinical trials, drug discovery, GlaxoSmithKline, machine learning, partnering, Target Discovery, Tempus 0 Comment

One of the first actions by GSK’s recently appointed chief scientific officer, Tony Wood, has been to expand

GSK turns to AI specialist Tempus for R&D productivity boost

https://pharmaphorum.com/news/gsk-turns-to-ai-specialist-tempus-for-rd-productivity-boost/

Science background with molecules and atoms

Digital/ News/ News/ Oncology/ R&D

Odyssey Therapeutics $168 million Series B financing oversubscribed

Nicole Raleigh AI, General Catalyst, immunology, Innovation, machine learning, Odyssey Therapeutics, Oncology, Series B financing 0 Comment

Biotech company Odyssey Therapeutics, Inc. has announced a $168 million Series B financing, led by global venture capital

Odyssey Therapeutics $168 million Series B financing oversubscribed

https://pharmaphorum.com/news/odyssey-therapeutics-168-million-series-b-financing-oversubscribed/

Digital/ Views & Analysis/ Views and analysis

Transforming oncology outcomes through data and digital

mike.hammerton@pharmaphorum.com AI, customer experience, data, digital health, machine learning, Takeda 0 Comment

The healthcare industry is evolving rapidly, with data and digital technologies transforming everyday communications as we know them.

Transforming oncology outcomes through data and digital

https://pharmaphorum.com/views-and-analysis/transforming-oncology-outcomes-through-data-digital/

Digital/ News/ News

Merck launches accelerator programme for AI startups

Phil Taylor accelerator, artificial intelligence, digital, digital health, Drug Discovery & Development, machine learning, Merck & Co 0 Comment

Merck & Co is looking for startup companies applying artificial intelligence, machine-learning and other digital approaches to drug

Merck launches accelerator programme for AI startups

https://pharmaphorum.com/news/merck-launches-accelerator-programme-for-ai-startups/

Digital/ News/ News

Boehringer backs AI-powered anti-infective startup ArrePath

Phil Taylor anti-infectives, antimicrobial resistance, ArrePath, artificial intelligence, digital, digital health, financing, machine learning 0 Comment

A new company set up to use machine learning to find new anti-infective drugs – ArrePath – has

Boehringer backs AI-powered anti-infective startup ArrePath

https://pharmaphorum.com/news/boehringer-backs-ai-powered-anti-infective-startup-arrepath/

doctor_touching_healthcare_icon_on_screen

Digital/ News/ News

Bayer-led project on AI in trials eyes ‘virtual’ placebo groups

Phil Taylor Aalto University, artificial intelligence, Bayer, clinical trials, Finland, Helsinki University Hospital, machine learning 0 Comment

Last year, Bayer launched a project to explore the use of artificial intelligence in clinical trials, working with

Bayer-led project on AI in trials eyes ‘virtual’ placebo groups

https://pharmaphorum.com/news/bayer-led-project-on-ai-in-trials-eyes-virtual-placebo-groups/

Trending

machine learning

Login